Cointime

Third Eye Diagnostics

company

About

Third Eye Diagnostics develops a non-invasive intracranial pressure monitor that gathers information from the patient's eye.

  • 1 - 10

Highlights

Total Funding Amount
$635K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$635K
Industries
Health Care,Health Diagnostics,Medical
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

Third Eye Diagnostics is developing the Cerepress, a first-of-its-kind non-invasive intracranial pressure monitor that gathers information from the patient's eye. The technology is based on one issued patent, one pending patent, and two applications in progress on methods and apparatus that correlate ICP with measurements taken from the blood vessels within the eye. The Cerepress measures blood pressure in the eye’s central retinal vein (CRV) which highly correlates to intracranial pressure.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$635K
Third Eye Diagnostics has raised a total of $635K in funding over 2 rounds. Their latest funding was raised on Jul 29, 2013 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 29, 2013 Grant $635K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Third Eye Diagnostics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Cointime
İçerikler
Şirket.